AI Article Synopsis
- SBRT is a promising prostate cancer treatment that delivers high doses of radiation in fewer sessions.
- Hypofractionation, used in SBRT, benefits from prostate cancer's low α:β ratio, making it more effective and sensitive to higher doses.
- The article explores the radiobiology, technical details, and clinical outcomes of using SBRT for prostate cancer management.
Article Abstract
Stereotactic body radiation therapy (SBRT) is a promising treatment option for prostate cancer. Hypofractionation regimens, such as SBRT, may be more advantageous compared with conventional regimens because low α:β ratio of prostate cancer has high sensitivity to dose per fraction. In addition, a smaller and tighter margin with SBRT is expected to provide a low toxicity rate without reducing tumor control. The purpose of this article is to examine radiobiological, technical and clinical aspects of SBRT for prostate cancer.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2217/fon.11.86 | DOI Listing |
Publication Analysis
Top Keywords
prostate cancer
16
stereotactic body
8
body radiation
8
radiation therapy
8
prostate
4
therapy prostate
4
cancer
4
cancer stereotactic
4
sbrt
4
therapy sbrt
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!